Yang Shen, MD

Trials

Studies that name Yang Shen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:05 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07664839 · Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations

  Shen yang · not yet recruiting · Acute Myeloid Leukemia, NPM1 Mutation, IDH1 Mutation · principal investigator
• N/A
  NCT06458244 · The Efficacy of Allo-HSCT in ND HR-CBF-AML

  Ruijin Hospital · recruiting · Acute Myeloid Leukemia · study director
• N/A
  NCT05734911 · Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study

  Zhongda Hospital · completed · Ovarian Neoplasms · study director
• Ph2
  NCT05422183 · Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

  Zhongda Hospital · unknown · Ovarian Cancer, Epithelial · study director
• N/A
  NCT04746352 · Effectiveness of Self-myofascial Release Combined With Biofeedback and Electrical Stimulation for the Management of MFPP

  Zhongda Hospital · completed · Myofascial Pelvic Pain · study director
• N/A
  NCT04695535 · Chemotherapy With Anlotinib in Advanced Cervical Cancer

  Yang Shen · unknown · Uterine Cervical Neoplasms · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.